Sorin stentless pericardial valve versus Carpentier-Edwards Perimount pericardial bioprosthesis: Is it worthwhile to struggle?
暂无分享,去创建一个
Fabio Miraldi | Lorenzo Spagnesi | Demetrio Tallarico | Gerardino Di Matteo | Gianluca Brancaccio | G. Brancaccio | F. Miraldi | D. Tallarico | L. Spagnesi | Gerardino Di Matteo
[1] Y. Hacıoğlu,et al. Short-Term Regression of Left Ventricular Mass After Aortic Valve Replacement in Aortic Stenosis With Left Ventricular Concentric Hypertrophy , 2002 .
[2] E. Topol,et al. First chronic platelet glycoprotein IIb/IIIa integrin blockade. A randomized, placebo-controlled pilot study of xemilofiban in unstable angina with percutaneous coronary interventions. , 1997, Circulation.
[3] G. Frati,et al. Early postoperative outcome and hemodynamic performance of the sorin pericarbon stentless aortic valve. , 2002, The Journal of heart valve disease.
[4] G. Vaccari,et al. The Sorin stentless pericardial valve: implant technique and hemodynamic profile. , 1999, Seminars in thoracic and cardiovascular surgery.
[5] D G Gibson,et al. Effects of valve substitute on changes in left ventricular function and hypertrophy after aortic valve replacement. , 1996, The Annals of thoracic surgery.
[6] M. Hlatky,et al. Functional capacity after cardiac surgery in elderly patients. , 1994, Journal of the American College of Cardiology.
[7] G Cohen,et al. Early experience with stentless versus stented valves. , 1997, Circulation.